Other
Finance Lease Right Of Use Asset Amortization
West Pharmaceutical Services Finance Lease Right Of Use Asset Amortization remained flat by 0.0% to $500K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.7%, from $300K to $500K.
Analysis
StatementCash Flow Statement
SectionOther
First reportedQ2 2023
Last reportedQ1 2026Apr 23, 2026
Metric ID:
other_finance_lease_right_of_use_asset_amortizationHistorical Data
9 periods
| Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $300K | $300K | $300K | $400K | $500K | $500K |
| QoQ Change | — | — | — | — | +0.0% | +0.0% | +33.3% | +25.0% | +0.0% |
| YoY Change | — | — | — | — | — | — | +33.3% | +66.7% | +66.7% |
Range$0 – $500K
Avg YoY Growth+55.6%
Median YoY Growth+66.7%
Current Streak5+ quarters growth
Finance Lease Right Of Use Asset Amortization at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's finance lease right of use asset amortization?
- West Pharmaceutical Services (WST) reported finance lease right of use asset amortization of $500K in Q1 2026.
- How has West Pharmaceutical Services's finance lease right of use asset amortization changed year-over-year?
- West Pharmaceutical Services's finance lease right of use asset amortization increased by 66.7% year-over-year, from $300K to $500K.